Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog

Conclusion: 131I-CLR1404 has the potential to become a tumor-targeted radiotherapeutic drug with broad applicability in pediatric oncology. Because 131I-CLR1404 has entered clinical trials in adults, our data warrant the development of pediatric clinical trials for this particularly vulnerable patient population.

Source: Journal of Nuclear Medicine - February 1, 2018 Category: Nuclear Medicine Authors: Baiu, D. C., Marsh, I. R., Boruch, A. E., Shahi, A., Bhattacharya, S., Jeffery, J. J., Zhao, Q., Hall, L. T., Weichert, J. P., Bednarz, B. P., Otto, M. Tags: Basic Source Type: research